Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
PubMed laboratory research record [PMID: 39219442] PubMed record related to this compound for laboratory literature review
The second study with 426 patients randomly assigned to TAK-875, placebo, or glimepiride treatment groups showed significant reductions in HbA1c levels from baseline in the TAK-875 (6.25 to 50 mg) and glimepiride (4 mg) treatment groups compared with the placebo group at week 12 [60]
Injection volumes become extremely small, which appeals to people who dislike the sensation of larger fluid volumes under the skin
MW: Writing review and editing, Conceptualization
January 2026
GLP-1 users who maintain consistent hydration and monitor urine output typically experience lower stone incidence, suggesting prevention is actionable and personalized
US$ 22.40
US$ 23.75
US$ 22.35
US$ 22.53
US$ 24.53
US$ 20.62
US$ 21.93
US$ 24.40
US$ 20.48
US$ 27.95
US$ 26.84
